: A five‐hour oral glucose tolerance test and simultaneous determinations of serum immunoreactive insulin were performed on 20 male and 20 female elderly nondiabetic subjects whose ages ranged from 68 to 91 years. Results of the glucose tolerance test were abnormal in 29 of the 40 subjects (72.5 per cent) according to accepted standards for young and middle‐aged normal adults. The abnormalities were similar to those found in cases of diabetes mellitus in young adults. The response to glucose stimulation in these elderly subjects was delayed and less efficient than normal. Significant differences were observed with respect to both serum glucose and immunoreactive insulin, the females exhibiting higher levels than the males. Regression analysis showed no immunoreactive insulin in the serum when the glucose level was less than 50 mg per 100 ml.
In 62 elderly subjects (age range, 66 to 100 years), fasting serum cholesterol and triglyceride concentrations were determined after three days of a high carbohydrate diet. Mean cholesterol levels were within accepted normal limits for the lower age groups and did not differ significantly between the age groups studied. Mean triglyceride levels were highest in the 70–79 age group and significantly lower in older subjects. Serum triglyceride values greater than 200 mg/100 ml were always associated with carbohydrate intolerance, and there was a highly significant correlation between fasting triglyceride concentration and fasting glucose concentration in the subjects with the more severe degrees of carbohydrate intolerance. There was no evidence of induction of hypertriglyceridemia by the high carbohydrate diet in these subjects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.